BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2737502)

  • 1. Neuroelectric procedure does not discriminate between painful and paresthetic diabetic neuropathy.
    Piaggesi A; Pasca S; Giannini C; Rossi B; Giampietro O; Angelotti M; Pulitanò L; Navalesi R
    Funct Neurol; 1989; 4(2):141-6. PubMed ID: 2737502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic neuropathy: a clinical, laboratory and electrodiagnostic study.
    Halar EM; Graf RJ; Halter JB; Brozovich FV; Soine TL
    Arch Phys Med Rehabil; 1982 Jul; 63(7):298-303. PubMed ID: 7092528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of diabetic neuropathy from pathogenetic aspects.
    Reichel G; Bruns W; Rabending G
    Endokrinologie; 1982 Jul; 79(3):321-36. PubMed ID: 6751812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of 2,3-DPG in nerve conduction of children with type 1 diabetes].
    Pańkowska E; Szypowska A; Wysocka M; Lipka M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(4):207-10. PubMed ID: 16232357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polyneuropathy index-revised in the evaluation of diabetic neuropathy].
    Hasegawa O; Matsumoto S; Gondo G; Arita T
    No To Shinkei; 2001 Mar; 53(3):259-63. PubMed ID: 11296400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration.
    Nicolucci A; Carinci F; Cavaliere D; Scorpiglione N; Belfiglio M; Labbrozzi D; Mari E; Benedetti MM; Tognoni G; Liberati A
    Diabet Med; 1996 Dec; 13(12):1017-26. PubMed ID: 8973882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible contribution of adipocytokines on diabetic neuropathy.
    Matsuda M; Kawasaki F; Inoue H; Kanda Y; Yamada K; Harada Y; Saito M; Eto M; Matsuki M; Kaku K
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S121-3. PubMed ID: 15563961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac autonomic involvement and peripheral nerve function in patients with diabetic neuropathy.
    Spitzer A; Lang E; Birklein F; Claus D; Neundörfer B
    Funct Neurol; 1997; 12(3-4):115-22. PubMed ID: 9218965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between limited joint mobility and peripheral nerve function in diabetic children.
    Fiçicioğlu C; Kiziltan M; Aydin A; Baslo P
    Turk J Pediatr; 1996; 38(4):431-7. PubMed ID: 8993172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor conduction velocity (MCV) in insulin-dependent and non-insulin-dependent diabetics with and without clinical peripheral neuropathy.
    Fedele D; Negrin P; Fardin P; Tiengo A
    Diabete Metab; 1980 Sep; 6(3):189-92. PubMed ID: 7439492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sural nerve conduction velocity and refractory period in diabetics without clinical signs of neuropathy.
    Schütt P; Muche H; Lehmann HJ; Hielscher H
    Horm Metab Res Suppl; 1980; 9():39-42. PubMed ID: 6929776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study of peripheral neural conduction, motor and sensory, in diabetic patients treated with hyperbaric oxygenation].
    Viera C; Gálvez C; Carrasco B; Santos C; Castellanos R
    Rev Neurol; 1999 May 1-15; 28(9):868-72. PubMed ID: 10390749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility of different methods for diagnosing and monitoring diabetic neuropathy.
    Nasseri K; Strijers RL; Dekhuijzen LS; Buster M; Bertelsmann FW
    Electromyogr Clin Neurophysiol; 1998; 38(5):295-9. PubMed ID: 9741007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral sensory nerve dysfunction in children and adolescents with type 1 diabetes mellitus.
    Barkai L; Kempler P; Vámosi I; Lukács K; Marton A; Keresztes K
    Diabet Med; 1998 Mar; 15(3):228-33. PubMed ID: 9545124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathy patterns differ in patients with diabetic complications.
    Kiziltan ME; Benbir G
    Electromyogr Clin Neurophysiol; 2008; 48(8):351-7. PubMed ID: 19097475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing of the refractory period in sensory nerve fibres is the most sensitive method to assess beginning polyneuropathy in diabetics.
    Braune HJ
    Electromyogr Clin Neurophysiol; 1999 Sep; 39(6):355-9. PubMed ID: 10499206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulse pressure is independently associated with sensorimotor peripheral neuropathy in patients with type 2 diabetes.
    Jarmuzewska EA; Mangoni AA
    J Intern Med; 2005 Jul; 258(1):38-44. PubMed ID: 15953131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison between Dyck's criteria and the polyneuropathy index-revised (PNI-R) in the electrophysiologic evaluation of diabetic neuropathy].
    Hasegawa O; Matsumoto S; Gondo G; Wada N; Arita T
    No To Shinkei; 2001 Nov; 53(11):1015-9. PubMed ID: 11761909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of determination of motor and sensory nerve conduction velocity in the diagnosis of diabetic neuropathy].
    Tang XF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 May; 15(2):78-81. PubMed ID: 7128314
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of metabolic control on peripheral diabetic neuropathy (author's transl)].
    Conte-Devolx B; Papy JJ; Conte-Devolx J; Rossi D; Fontaine G; Codaccioni JL
    Nouv Presse Med; 1981 Oct; 10(39):3221-3. PubMed ID: 7029456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.